Global Rheumatoid Arthritis Medicine Supply, Demand and Key Producers, 2023-2029
Page: 108
Published Date: 06 Sep 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Rheumatoid Arthritis Medicine market size is expected to reach $ 494.8 million by 2029, rising at a market growth of 4.3% CAGR during the forecast period (2023-2029).
Rheumatoid Arthritis is an autoimmune disease that causes pain, swelling, and stiffness in the joints, and may cause severe joint damage, loss of function, and disability. The disease may last from months to a lifetime, and symptoms may improve and worsen over time.
This report studies the global Rheumatoid Arthritis Medicine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Rheumatoid Arthritis Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rheumatoid Arthritis Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Rheumatoid Arthritis Medicine total production and demand, 2018-2029, (K Units)
Global Rheumatoid Arthritis Medicine total production value, 2018-2029, (USD Million)
Global Rheumatoid Arthritis Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Rheumatoid Arthritis Medicine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Rheumatoid Arthritis Medicine domestic production, consumption, key domestic manufacturers and share
Global Rheumatoid Arthritis Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Rheumatoid Arthritis Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Rheumatoid Arthritis Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Rheumatoid Arthritis Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp and Biogen Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rheumatoid Arthritis Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Rheumatoid Arthritis Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Rheumatoid Arthritis Medicine Market, Segmentation by Type
Prescription Drugs
OTC Drugs
Global Rheumatoid Arthritis Medicine Market, Segmentation by Application
Hospital
Clinics
Others
Companies Profiled:
AbbVie Inc
Hoffman-La Roche AG
Amgen Inc
Pfizer Inc
Bristol-Myers Squibb Co
Johnson & Johnson
UCB Biosciences Inc
Mitsubishi Tanabe Pharma Corp
Biogen Inc
Merck & Co
Haute Autorité de Santé
Key Questions Answered
1. How big is the global Rheumatoid Arthritis Medicine market?
2. What is the demand of the global Rheumatoid Arthritis Medicine market?
3. What is the year over year growth of the global Rheumatoid Arthritis Medicine market?
4. What is the production and production value of the global Rheumatoid Arthritis Medicine market?
5. Who are the key producers in the global Rheumatoid Arthritis Medicine market?
Table of Contents
1 Supply Summary
1.1 Rheumatoid Arthritis Medicine Introduction
1.2 World Rheumatoid Arthritis Medicine Supply & Forecast
1.2.1 World Rheumatoid Arthritis Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Rheumatoid Arthritis Medicine Production (2018-2029)
1.2.3 World Rheumatoid Arthritis Medicine Pricing Trends (2018-2029)
1.3 World Rheumatoid Arthritis Medicine Production by Region (Based on Production Site)
1.3.1 World Rheumatoid Arthritis Medicine Production Value by Region (2018-2029)
1.3.2 World Rheumatoid Arthritis Medicine Production by Region (2018-2029)
1.3.3 World Rheumatoid Arthritis Medicine Average Price by Region (2018-2029)
1.3.4 North America Rheumatoid Arthritis Medicine Production (2018-2029)
1.3.5 Europe Rheumatoid Arthritis Medicine Production (2018-2029)
1.3.6 China Rheumatoid Arthritis Medicine Production (2018-2029)
1.3.7 Japan Rheumatoid Arthritis Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Rheumatoid Arthritis Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Rheumatoid Arthritis Medicine Major Market Trends
2.1 World Rheumatoid Arthritis Medicine Demand (2018-2029)
2.2 World Rheumatoid Arthritis Medicine Consumption by Region
2.2.1 World Rheumatoid Arthritis Medicine Consumption by Region (2018-2023)
2.2.2 World Rheumatoid Arthritis Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Rheumatoid Arthritis Medicine Consumption (2018-2029)
2.4 China Rheumatoid Arthritis Medicine Consumption (2018-2029)
2.5 Europe Rheumatoid Arthritis Medicine Consumption (2018-2029)
2.6 Japan Rheumatoid Arthritis Medicine Consumption (2018-2029)
2.7 South Korea Rheumatoid Arthritis Medicine Consumption (2018-2029)
2.8 ASEAN Rheumatoid Arthritis Medicine Consumption (2018-2029)
2.9 India Rheumatoid Arthritis Medicine Consumption (2018-2029)
3.1 World Rheumatoid Arthritis Medicine Production Value by Manufacturer (2018-2023)
3.2 World Rheumatoid Arthritis Medicine Production by Manufacturer (2018-2023)
3.3 World Rheumatoid Arthritis Medicine Average Price by Manufacturer (2018-2023)
3.4 Rheumatoid Arthritis Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Rheumatoid Arthritis Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Rheumatoid Arthritis Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Rheumatoid Arthritis Medicine in 2022
3.6 Rheumatoid Arthritis Medicine Market: Overall Company Footprint Analysis
3.6.1 Rheumatoid Arthritis Medicine Market: Region Footprint
3.6.2 Rheumatoid Arthritis Medicine Market: Company Product Type Footprint
3.6.3 Rheumatoid Arthritis Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Rheumatoid Arthritis Medicine Production Value Comparison
4.1.1 United States VS China: Rheumatoid Arthritis Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Rheumatoid Arthritis Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Rheumatoid Arthritis Medicine Production Comparison
4.2.1 United States VS China: Rheumatoid Arthritis Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Rheumatoid Arthritis Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Rheumatoid Arthritis Medicine Consumption Comparison
4.3.1 United States VS China: Rheumatoid Arthritis Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Rheumatoid Arthritis Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Rheumatoid Arthritis Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Rheumatoid Arthritis Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Rheumatoid Arthritis Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Rheumatoid Arthritis Medicine Production (2018-2023)
4.5 China Based Rheumatoid Arthritis Medicine Manufacturers and Market Share
4.5.1 China Based Rheumatoid Arthritis Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Rheumatoid Arthritis Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Rheumatoid Arthritis Medicine Production (2018-2023)
4.6 Rest of World Based Rheumatoid Arthritis Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Rheumatoid Arthritis Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production (2018-2023)
5.1 World Rheumatoid Arthritis Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drugs
5.2.2 OTC Drugs
5.3 Market Segment by Type
5.3.1 World Rheumatoid Arthritis Medicine Production by Type (2018-2029)
5.3.2 World Rheumatoid Arthritis Medicine Production Value by Type (2018-2029)
5.3.3 World Rheumatoid Arthritis Medicine Average Price by Type (2018-2029)
6.1 World Rheumatoid Arthritis Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Rheumatoid Arthritis Medicine Production by Application (2018-2029)
6.3.2 World Rheumatoid Arthritis Medicine Production Value by Application (2018-2029)
6.3.3 World Rheumatoid Arthritis Medicine Average Price by Application (2018-2029)
7.1 AbbVie Inc
7.1.1 AbbVie Inc Details
7.1.2 AbbVie Inc Major Business
7.1.3 AbbVie Inc Rheumatoid Arthritis Medicine Product and Services
7.1.4 AbbVie Inc Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Inc Recent Developments/Updates
7.1.6 AbbVie Inc Competitive Strengths & Weaknesses
7.2 Hoffman-La Roche AG
7.2.1 Hoffman-La Roche AG Details
7.2.2 Hoffman-La Roche AG Major Business
7.2.3 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product and Services
7.2.4 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Hoffman-La Roche AG Recent Developments/Updates
7.2.6 Hoffman-La Roche AG Competitive Strengths & Weaknesses
7.3 Amgen Inc
7.3.1 Amgen Inc Details
7.3.2 Amgen Inc Major Business
7.3.3 Amgen Inc Rheumatoid Arthritis Medicine Product and Services
7.3.4 Amgen Inc Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Inc Recent Developments/Updates
7.3.6 Amgen Inc Competitive Strengths & Weaknesses
7.4 Pfizer Inc
7.4.1 Pfizer Inc Details
7.4.2 Pfizer Inc Major Business
7.4.3 Pfizer Inc Rheumatoid Arthritis Medicine Product and Services
7.4.4 Pfizer Inc Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Inc Recent Developments/Updates
7.4.6 Pfizer Inc Competitive Strengths & Weaknesses
7.5 Bristol-Myers Squibb Co
7.5.1 Bristol-Myers Squibb Co Details
7.5.2 Bristol-Myers Squibb Co Major Business
7.5.3 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product and Services
7.5.4 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Bristol-Myers Squibb Co Recent Developments/Updates
7.5.6 Bristol-Myers Squibb Co Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Rheumatoid Arthritis Medicine Product and Services
7.6.4 Johnson & Johnson Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 UCB Biosciences Inc
7.7.1 UCB Biosciences Inc Details
7.7.2 UCB Biosciences Inc Major Business
7.7.3 UCB Biosciences Inc Rheumatoid Arthritis Medicine Product and Services
7.7.4 UCB Biosciences Inc Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 UCB Biosciences Inc Recent Developments/Updates
7.7.6 UCB Biosciences Inc Competitive Strengths & Weaknesses
7.8 Mitsubishi Tanabe Pharma Corp
7.8.1 Mitsubishi Tanabe Pharma Corp Details
7.8.2 Mitsubishi Tanabe Pharma Corp Major Business
7.8.3 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product and Services
7.8.4 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Mitsubishi Tanabe Pharma Corp Recent Developments/Updates
7.8.6 Mitsubishi Tanabe Pharma Corp Competitive Strengths & Weaknesses
7.9 Biogen Inc
7.9.1 Biogen Inc Details
7.9.2 Biogen Inc Major Business
7.9.3 Biogen Inc Rheumatoid Arthritis Medicine Product and Services
7.9.4 Biogen Inc Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Biogen Inc Recent Developments/Updates
7.9.6 Biogen Inc Competitive Strengths & Weaknesses
7.10 Merck & Co
7.10.1 Merck & Co Details
7.10.2 Merck & Co Major Business
7.10.3 Merck & Co Rheumatoid Arthritis Medicine Product and Services
7.10.4 Merck & Co Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Merck & Co Recent Developments/Updates
7.10.6 Merck & Co Competitive Strengths & Weaknesses
7.11 Haute Autorité de Santé
7.11.1 Haute Autorité de Santé Details
7.11.2 Haute Autorité de Santé Major Business
7.11.3 Haute Autorité de Santé Rheumatoid Arthritis Medicine Product and Services
7.11.4 Haute Autorité de Santé Rheumatoid Arthritis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Haute Autorité de Santé Recent Developments/Updates
7.11.6 Haute Autorité de Santé Competitive Strengths & Weaknesses
8.1 Rheumatoid Arthritis Medicine Industry Chain
8.2 Rheumatoid Arthritis Medicine Upstream Analysis
8.2.1 Rheumatoid Arthritis Medicine Core Raw Materials
8.2.2 Main Manufacturers of Rheumatoid Arthritis Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Rheumatoid Arthritis Medicine Production Mode
8.6 Rheumatoid Arthritis Medicine Procurement Model
8.7 Rheumatoid Arthritis Medicine Industry Sales Model and Sales Channels
8.7.1 Rheumatoid Arthritis Medicine Sales Model
8.7.2 Rheumatoid Arthritis Medicine Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Rheumatoid Arthritis Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Rheumatoid Arthritis Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Rheumatoid Arthritis Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Rheumatoid Arthritis Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Rheumatoid Arthritis Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Rheumatoid Arthritis Medicine Production by Region (2018-2023) & (K Units)
Table 7. World Rheumatoid Arthritis Medicine Production by Region (2024-2029) & (K Units)
Table 8. World Rheumatoid Arthritis Medicine Production Market Share by Region (2018-2023)
Table 9. World Rheumatoid Arthritis Medicine Production Market Share by Region (2024-2029)
Table 10. World Rheumatoid Arthritis Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Rheumatoid Arthritis Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Rheumatoid Arthritis Medicine Major Market Trends
Table 13. World Rheumatoid Arthritis Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Rheumatoid Arthritis Medicine Consumption by Region (2018-2023) & (K Units)
Table 15. World Rheumatoid Arthritis Medicine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Rheumatoid Arthritis Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Rheumatoid Arthritis Medicine Producers in 2022
Table 18. World Rheumatoid Arthritis Medicine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Rheumatoid Arthritis Medicine Producers in 2022
Table 20. World Rheumatoid Arthritis Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Rheumatoid Arthritis Medicine Company Evaluation Quadrant
Table 22. World Rheumatoid Arthritis Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Rheumatoid Arthritis Medicine Production Site of Key Manufacturer
Table 24. Rheumatoid Arthritis Medicine Market: Company Product Type Footprint
Table 25. Rheumatoid Arthritis Medicine Market: Company Product Application Footprint
Table 26. Rheumatoid Arthritis Medicine Competitive Factors
Table 27. Rheumatoid Arthritis Medicine New Entrant and Capacity Expansion Plans
Table 28. Rheumatoid Arthritis Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Rheumatoid Arthritis Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Rheumatoid Arthritis Medicine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Rheumatoid Arthritis Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Rheumatoid Arthritis Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Rheumatoid Arthritis Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Rheumatoid Arthritis Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Rheumatoid Arthritis Medicine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Rheumatoid Arthritis Medicine Production Market Share (2018-2023)
Table 37. China Based Rheumatoid Arthritis Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Rheumatoid Arthritis Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Rheumatoid Arthritis Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Rheumatoid Arthritis Medicine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Rheumatoid Arthritis Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Rheumatoid Arthritis Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production Market Share (2018-2023)
Table 47. World Rheumatoid Arthritis Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Rheumatoid Arthritis Medicine Production by Type (2018-2023) & (K Units)
Table 49. World Rheumatoid Arthritis Medicine Production by Type (2024-2029) & (K Units)
Table 50. World Rheumatoid Arthritis Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Rheumatoid Arthritis Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Rheumatoid Arthritis Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Rheumatoid Arthritis Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Rheumatoid Arthritis Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Rheumatoid Arthritis Medicine Production by Application (2018-2023) & (K Units)
Table 56. World Rheumatoid Arthritis Medicine Production by Application (2024-2029) & (K Units)
Table 57. World Rheumatoid Arthritis Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Rheumatoid Arthritis Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Rheumatoid Arthritis Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Rheumatoid Arthritis Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Inc Major Business
Table 63. AbbVie Inc Rheumatoid Arthritis Medicine Product and Services
Table 64. AbbVie Inc Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AbbVie Inc Recent Developments/Updates
Table 66. AbbVie Inc Competitive Strengths & Weaknesses
Table 67. Hoffman-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 68. Hoffman-La Roche AG Major Business
Table 69. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product and Services
Table 70. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Hoffman-La Roche AG Recent Developments/Updates
Table 72. Hoffman-La Roche AG Competitive Strengths & Weaknesses
Table 73. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Inc Major Business
Table 75. Amgen Inc Rheumatoid Arthritis Medicine Product and Services
Table 76. Amgen Inc Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Inc Recent Developments/Updates
Table 78. Amgen Inc Competitive Strengths & Weaknesses
Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc Major Business
Table 81. Pfizer Inc Rheumatoid Arthritis Medicine Product and Services
Table 82. Pfizer Inc Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Pfizer Inc Competitive Strengths & Weaknesses
Table 85. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 86. Bristol-Myers Squibb Co Major Business
Table 87. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product and Services
Table 88. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bristol-Myers Squibb Co Recent Developments/Updates
Table 90. Bristol-Myers Squibb Co Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Rheumatoid Arthritis Medicine Product and Services
Table 94. Johnson & Johnson Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. UCB Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 98. UCB Biosciences Inc Major Business
Table 99. UCB Biosciences Inc Rheumatoid Arthritis Medicine Product and Services
Table 100. UCB Biosciences Inc Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. UCB Biosciences Inc Recent Developments/Updates
Table 102. UCB Biosciences Inc Competitive Strengths & Weaknesses
Table 103. Mitsubishi Tanabe Pharma Corp Basic Information, Manufacturing Base and Competitors
Table 104. Mitsubishi Tanabe Pharma Corp Major Business
Table 105. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product and Services
Table 106. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Mitsubishi Tanabe Pharma Corp Recent Developments/Updates
Table 108. Mitsubishi Tanabe Pharma Corp Competitive Strengths & Weaknesses
Table 109. Biogen Inc Basic Information, Manufacturing Base and Competitors
Table 110. Biogen Inc Major Business
Table 111. Biogen Inc Rheumatoid Arthritis Medicine Product and Services
Table 112. Biogen Inc Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Biogen Inc Recent Developments/Updates
Table 114. Biogen Inc Competitive Strengths & Weaknesses
Table 115. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 116. Merck & Co Major Business
Table 117. Merck & Co Rheumatoid Arthritis Medicine Product and Services
Table 118. Merck & Co Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Merck & Co Recent Developments/Updates
Table 120. Haute Autorité de Santé Basic Information, Manufacturing Base and Competitors
Table 121. Haute Autorité de Santé Major Business
Table 122. Haute Autorité de Santé Rheumatoid Arthritis Medicine Product and Services
Table 123. Haute Autorité de Santé Rheumatoid Arthritis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Rheumatoid Arthritis Medicine Upstream (Raw Materials)
Table 125. Rheumatoid Arthritis Medicine Typical Customers
Table 126. Rheumatoid Arthritis Medicine Typical Distributors
List of Figure
Figure 1. Rheumatoid Arthritis Medicine Picture
Figure 2. World Rheumatoid Arthritis Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rheumatoid Arthritis Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Rheumatoid Arthritis Medicine Production (2018-2029) & (K Units)
Figure 5. World Rheumatoid Arthritis Medicine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Rheumatoid Arthritis Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Rheumatoid Arthritis Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Rheumatoid Arthritis Medicine Production (2018-2029) & (K Units)
Figure 9. Europe Rheumatoid Arthritis Medicine Production (2018-2029) & (K Units)
Figure 10. China Rheumatoid Arthritis Medicine Production (2018-2029) & (K Units)
Figure 11. Japan Rheumatoid Arthritis Medicine Production (2018-2029) & (K Units)
Figure 12. Rheumatoid Arthritis Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 15. World Rheumatoid Arthritis Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 17. China Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 18. Europe Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 19. Japan Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 22. India Rheumatoid Arthritis Medicine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Rheumatoid Arthritis Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Rheumatoid Arthritis Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Rheumatoid Arthritis Medicine Markets in 2022
Figure 26. United States VS China: Rheumatoid Arthritis Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Rheumatoid Arthritis Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rheumatoid Arthritis Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Rheumatoid Arthritis Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Rheumatoid Arthritis Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Rheumatoid Arthritis Medicine Production Market Share 2022
Figure 32. World Rheumatoid Arthritis Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Rheumatoid Arthritis Medicine Production Value Market Share by Type in 2022
Figure 34. Prescription Drugs
Figure 35. OTC Drugs
Figure 36. World Rheumatoid Arthritis Medicine Production Market Share by Type (2018-2029)
Figure 37. World Rheumatoid Arthritis Medicine Production Value Market Share by Type (2018-2029)
Figure 38. World Rheumatoid Arthritis Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Rheumatoid Arthritis Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Rheumatoid Arthritis Medicine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinics
Figure 43. Others
Figure 44. World Rheumatoid Arthritis Medicine Production Market Share by Application (2018-2029)
Figure 45. World Rheumatoid Arthritis Medicine Production Value Market Share by Application (2018-2029)
Figure 46. World Rheumatoid Arthritis Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Rheumatoid Arthritis Medicine Industry Chain
Figure 48. Rheumatoid Arthritis Medicine Procurement Model
Figure 49. Rheumatoid Arthritis Medicine Sales Model
Figure 50. Rheumatoid Arthritis Medicine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AbbVie Inc Hoffman-La Roche AG Amgen Inc Pfizer Inc Bristol-Myers Squibb Co Johnson & Johnson UCB Biosciences Inc Mitsubishi Tanabe Pharma Corp Biogen Inc Merck & Co Haute Autorité de Santé
Related Reports
06 Sep 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
